Skip to main content
Neurology logoLink to Neurology
. 2019 Aug 20;93(8):371. doi: 10.1212/WNL.0000000000007919

INTREPAD

A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

PMCID: PMC7508313  PMID: 31427496

In the article “INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease" by Meyer et al.,1 first published online April 5, 2019, Dr. Lafaille-Magnan’s name should appear in the author list as Marie-Elyse Lafaille-Magnan. The authors regret the error.

Reference

  • 1.Meyer PF, Tremblay-Mercier J, Leoutsakos J, et al. INTREPAD: a randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology 2019;92:e2070--e2080. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology are provided here courtesy of American Academy of Neurology

RESOURCES